<p><strong>1st Detect Corporation 在全球部署的检测和分析质谱系统能够减少误报并加强安检筛查</strong></p>
<p><strong>德克萨斯州奥斯丁，2025 年 12 月 12 日（GLOBE NEWSWIRE）--</strong> Astrotech Corporation（纳斯达克：ASTC）（“公司” 或 “Astrotech”）今天宣布支持国土安全部（“DHS”）最近的全国航空安全筛查和技术现代化倡议。2025 年 11 月 22 日，DHS 部长 Kristi Noem 宣布了一项价值 10 亿美元的全国计划，以升级运输安全管理局（“TSA”）的设备和安全筛查。1st Detect Corporation 已准备好部署其 TRACER 1000™检测系统以支持此类倡议。</p>
<p>公司的 TRACER 1000 检测系统已获得 TSA 用于航空货物筛查和欧洲民航会议用于航空安全应用的批准，利用质谱技术在可现场部署的系统中提供实验室级别的痕量检测。虽然 TRACER 1000 在国际机场和美国各地的货物设施中已投入使用，但该技术尚未在美国的乘客筛查检查站部署。</p>
<p>DHS 的现代化倡议解决了一个重要需求，因为机场在管理创纪录的乘客流量时面临日益复杂的威胁。传统的筛查技术可能具有较高的相对误报率，这导致操作速度变慢、成本增加以及旅客的压力加大。</p>
<p>“美国航空安全不仅仅是检测已知威胁，而是建立足够韧性的系统，以应对我们尚未遇到的威胁，” Astrotech Corporation 和 1st Detect 的董事长兼首席执行官 Thomas B. Pickens III 表示。“质谱技术在现场设定了实验室级别的精确标准，能够检测传统筛查常常误分类的微量物质。随着 DHS 对这一关键基础设施的现代化，我们相信我们已准备好提供不仅符合今天标准而且设定明天标准的技术。”</p>
<p><strong>应对误报挑战</strong></p>
<p>基于质谱的检测的一个关键优势是与传统筛查技术相比，误报率的降低。误报会造成一系列操作问题，包括延长检查站的延误、浪费安保人员的时间、错过航班以及乘客的沮丧。通过提供对威胁物质的更准确的分子识别，TRACER 1000 可以帮助安保团队将资源集中在真正的威胁上，而不是调查那些引发误报的无害物质。</p>
<p><strong>立即扩展的能力</strong></p>
<p>与需要数年开发或制造提升的技术不同，Astrotech 相信 1st Detect 拥有立即扩大生产以满足 DHS 现代化计划预期需求的基础设施和能力。公司认为其位于德克萨斯州奥斯丁的设施能够支持快速部署，因为机场和联邦机构正在实施升级的筛查基础设施。</p>
<p>“我们提供经过测试、认证并准备部署的技术，今天在一些世界上最繁忙的机场中已投入使用，” Pickens 补充道。“我们相信我们有能力扩大生产以满足 Noem 部长所概述的时间表。”</p>
<p><strong>支持国家安全优先事项</strong></p>
<p>DHS 航空安全现代化计划代表了对筛查基础设施的重大投资。随着该倡议从规划阶段转向实施，1st Detect 和 Astrotech 打算与联邦机构、机场管理局和行业利益相关者进行接触，展示如何利用其质谱技术的检测和分析来增强安全态势，同时提高操作效率。</p>
<p>对于希望了解 TRACER 1000 的能力和部署时间表的机场和安全专业人士，1st Detect 可提供简报、演示和技术咨询。</p>
<p><strong>关于 1st Detect</strong></p>
<p>1st Detect 总部位于德克萨斯州奥斯丁，开发、制造和销售用于安全和检测市场的痕量探测器。作为 Astrotech Corporation（纳斯达克：ASTC）的子公司，该公司的 TRACER 1000 ETD®和 TRACER 1000 NTD™系统在为现实环境设计的便携式设备中提供实验室级别的性能。</p>
<p>欲了解更多信息，请访问 https://1stdetect.com。</p>
<p><strong>关于 Astrotech Corporation</strong></p>
<p>Astrotech Corporation（纳斯达克：ASTC）是一家质谱公司，通过其全资子公司创建、运营和扩展创新业务。每个子公司利用 Astrotech 的核心技术服务于专业市场：</p>
<ul>
<li>1st Detect 开发、制造和销售用于安全和毒品筛查应用的痕量检测系统。</li>
<li>AgLAB 设计针对农业行业的过程分析仪。</li>
<li>Pro-Control 生产用于工业制造中的原位化学过程控制的解决方案。</li>
<li>BreathTech 正在推进一种呼吸分析平台，以检测与感染和重大健康状况相关的挥发性有机化合物（VOCs）。</li>
<li>EN-SCAN, Inc.提供便携式、坚固的环境测试解决方案，集成气相色谱和质谱，适用于具有挑战性的现场环境。</li>
</ul>
<p>Astrotech 总部位于德克萨斯州奥斯丁。欲了解更多信息，请访问 https://www.astrotechcorp.com。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含根据 1995 年《私人证券诉讼改革法案》的安全港条款所作的前瞻性声明。前瞻性声明可能包括 “可能”、“将”、“计划”、“相信”、“估计”、“期望”、“打算” 等类似表达。这些前瞻性声明受到风险、趋势和不确定性的影响，这些因素可能导致实际结果与前瞻性声明存在重大差异。这些因素包括但不限于通货膨胀压力的负面影响，包括燃料成本的显著增加、全球经济状况及与这些状况相关的事件，包括乌克兰和中东的持续战争、公司对普通股发行收益的使用、我们是否能够成功完成新产品和专有技术的开发、我们是否能够获得在美国或国外市场销售我们正在开发的产品所需的 FDA 及其他监管批准、市场是否会接受我们的产品和服务，以及我们在识别、完成和整合收购方面的成功与否，以及公司在证券交易委员会的备案文件中描述的其他风险因素和商业考虑，包括公司最近的 10-K 表格年度报告和 10-Q 表格季度报告。本文档中的任何前瞻性声明应根据这些重要风险因素进行评估。虽然我们不打算直接收获、制造、分销或销售大麻或大麻产品，但我们可能会受到联邦或州政府执法变化的负面影响，并且我们可能会面临与不断变化的监管领域及相关不确定性有关的额外风险。任何此类影响可能会导致当前未知的风险和不确定性，或加剧本文提到的其他风险。尽管公司相信其前瞻性声明中反映的预期是合理的，并基于合理的假设，但不能保证这些假设是准确的，或这些预期中的任何一个（全部或部分）将会实现，或将被证明是正确的。此外，这些声明受到许多假设、风险和不确定性的影响，其中许多超出了公司的控制范围，可能导致实际结果与前瞻性声明所暗示或表达的结果存在重大差异。此外，本新闻稿中包含的任何前瞻性声明仅代表公司在发布之日的观点，不应被视为公司在任何后续日期的观点。公司不承担因新信息、未来事件或其他原因而更正或更新这些前瞻性声明的义务，除非适用法律要求。</p>
<p><strong>投资者联系：Matt Kreps，董事总经理，Darrow Associates，(214) 597-8200，mkreps@darrowir.com。</strong></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZd01UWTFOU00zTXpJd016STRJelV3TURFd09EQTVPUT09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZd01UWTFOU00zTXpJd016STRJelV3TURFd09EQTVPUT09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MjhhMWZlMjYtMDQwYi00MjQ4LTlkNzktMmJiOWFmZThmMTcxLTUwMDEwODA5OS0yMDI1LTEyLTEyLWVu/tiny/Astrotech-Corporation.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MjhhMWZlMjYtMDQwYi00MjQ4LTlkNzktMmJiOWFmZThmMTcxLTUwMDEwODA5OS0yMDI1LTEyLTEyLWVu/tiny/Astrotech-Corporation.png"/></p>

ASTC

<p>Astrotech Corporation 支持国土安全部（DHS）10 亿美元的航空安全现代化计划。其 TRACER 1000 系统利用质谱技术，旨在减少误报并提高筛查效率。该技术已准备好在美国乘客安检点部署，以应对日益增加的威胁和乘客数量。Astrotech 计划扩大生产以满足需求，并与联邦机构和利益相关者合作，展示其能力</p>

<p><strong>1st Detect Corporation's detection and analysis mass spectrometry systems deployed worldwide offer the ability to reduce false alarms and strengthen checkpoint screening</strong></p>
<div class="lb-trans"><p><strong>1st Detect Corporation 在全球部署的检测和分析质谱系统能够减少误报并加强安检筛查</strong></p>
</div><p><strong>AUSTIN, Texas, Dec. 12, 2025 (GLOBE NEWSWIRE) --</strong> Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced its support of the Department of Homeland Security’s (“DHS”) recent initiative to modernize aviation security screening and technology nationwide. On November 22, 2025, DHS Secretary Kristi Noem announced a $1 billion nationwide plan to upgrade Transportation Security Administration (“TSA”) equipment and security screening. 1st Detect Corporation stands ready to deploy its TRACER 1000™ detection systems to support such initiatives.</p>
<div class="lb-trans"><p><strong>德克萨斯州奥斯丁，2025 年 12 月 12 日（GLOBE NEWSWIRE）--</strong> Astrotech Corporation（纳斯达克：ASTC）（“公司” 或 “Astrotech”）今天宣布支持国土安全部（“DHS”）最近的全国航空安全筛查和技术现代化倡议。2025 年 11 月 22 日，DHS 部长 Kristi Noem 宣布了一项价值 10 亿美元的全国计划，以升级运输安全管理局（“TSA”）的设备和安全筛查。1st Detect Corporation 已准备好部署其 TRACER 1000™检测系统以支持此类倡议。</p>
</div><p>The Company's TRACER 1000 detection systems, approved by both the TSA for air cargo screening and the European Civil Aviation Conference for aviation security applications, use mass spectrometry to deliver laboratory-grade trace detection in field-deployable systems. While TRACER 1000 is operational at airports internationally and cargo facilities across the United States, the technology has not yet been deployed at U.S. passenger screening checkpoints.</p>
<div class="lb-trans"><p>公司的 TRACER 1000 检测系统已获得 TSA 用于航空货物筛查和欧洲民航会议用于航空安全应用的批准，利用质谱技术在可现场部署的系统中提供实验室级别的痕量检测。虽然 TRACER 1000 在国际机场和美国各地的货物设施中已投入使用，但该技术尚未在美国的乘客筛查检查站部署。</p>
</div><p>The DHS modernization initiative addresses an important need as airports manage record passenger volumes while facing increasingly sophisticated threats. Traditional screening technologies can have higher relative false alarm rates, which result in slower operations, increased costs, and more stress for travelers.</p>
<div class="lb-trans"><p>DHS 的现代化倡议解决了一个重要需求，因为机场在管理创纪录的乘客流量时面临日益复杂的威胁。传统的筛查技术可能具有较高的相对误报率，这导致操作速度变慢、成本增加以及旅客的压力加大。</p>
</div><p>&#34;American aviation security isn't just about detecting known threats, it's about building systems resilient enough for threats we haven't encountered yet,&#34; said Thomas B. Pickens III, Chairman and CEO of Astrotech Corporation and 1st Detect. &#34;Mass spectrometry set the standard, lab-grade precision in the field, detecting trace amounts that traditional screening often miscategorizes. As DHS modernizes this critical infrastructure, we believe we are ready to deliver technology that doesn't just meet today's standards but sets tomorrow's.&#34;</p>
<div class="lb-trans"><p>“美国航空安全不仅仅是检测已知威胁，而是建立足够韧性的系统，以应对我们尚未遇到的威胁，” Astrotech Corporation 和 1st Detect 的董事长兼首席执行官 Thomas B. Pickens III 表示。“质谱技术在现场设定了实验室级别的精确标准，能够检测传统筛查常常误分类的微量物质。随着 DHS 对这一关键基础设施的现代化，我们相信我们已准备好提供不仅符合今天标准而且设定明天标准的技术。”</p>
</div><p><strong>Addressing the False Alarm Challenge</strong></p>
<div class="lb-trans"><p><strong>应对误报挑战</strong></p>
</div><p>A key advantage of mass spectrometry-based detection is the reduction in false alarm rates compared to conventional screening technologies. False alarms create cascading operational problems, including extended checkpoint delays, wasted security personnel time, missed flights, and frustrated passengers. By providing more accurate molecular identification of threat substances, TRACER 1000 can help security teams focus resources on genuine threats rather than investigating harmless substances that trigger false positives.</p>
<div class="lb-trans"><p>基于质谱的检测的一个关键优势是与传统筛查技术相比，误报率的降低。误报会造成一系列操作问题，包括延长检查站的延误、浪费安保人员的时间、错过航班以及乘客的沮丧。通过提供对威胁物质的更准确的分子识别，TRACER 1000 可以帮助安保团队将资源集中在真正的威胁上，而不是调查那些引发误报的无害物质。</p>
</div><p><strong>Immediate Capacity to Scale</strong></p>
<div class="lb-trans"><p><strong>立即扩展的能力</strong></p>
</div><p>Unlike technologies that require years of development or manufacturing ramp-up, Astrotech believes that 1st Detect has the infrastructure and capacity to expand production immediately to meet anticipated demand from the DHS modernization program. The Company believes that its Austin, Texas, facility is positioned to support rapid deployment as airports and federal agencies implement upgraded screening infrastructure.</p>
<div class="lb-trans"><p>与需要数年开发或制造提升的技术不同，Astrotech 相信 1st Detect 拥有立即扩大生产以满足 DHS 现代化计划预期需求的基础设施和能力。公司认为其位于德克萨斯州奥斯丁的设施能够支持快速部署，因为机场和联邦机构正在实施升级的筛查基础设施。</p>
</div><p>&#34;We are offering tested, certified, and ready to deploy technology that is operational today in some of the world's busiest airports,&#34; Pickens added. &#34;We believe we have the capability to scale production to meet the timeline Secretary Noem has outlined.&#34;</p>
<div class="lb-trans"><p>“我们提供经过测试、认证并准备部署的技术，今天在一些世界上最繁忙的机场中已投入使用，” Pickens 补充道。“我们相信我们有能力扩大生产以满足 Noem 部长所概述的时间表。”</p>
</div><p><strong>Supporting a National Security Priority</strong></p>
<div class="lb-trans"><p><strong>支持国家安全优先事项</strong></p>
</div><p>The DHS aviation security modernization plan represents a substantial investment in screening infrastructure. As the initiative moves from planning to implementation, 1st Detect and Astrotech intend to engage with federal agencies, airport authorities, and industry stakeholders to demonstrate how detection and analysis with its mass spectrometry technology can strengthen security posture while improving operational efficiency.</p>
<div class="lb-trans"><p>DHS 航空安全现代化计划代表了对筛查基础设施的重大投资。随着该倡议从规划阶段转向实施，1st Detect 和 Astrotech 打算与联邦机构、机场管理局和行业利益相关者进行接触，展示如何利用其质谱技术的检测和分析来增强安全态势，同时提高操作效率。</p>
</div><p>For airports and security professionals interested in learning more about TRACER 1000's capabilities and deployment timelines, 1st Detect is available for briefings, demonstrations, and technical consultations.</p>
<div class="lb-trans"><p>对于希望了解 TRACER 1000 的能力和部署时间表的机场和安全专业人士，1st Detect 可提供简报、演示和技术咨询。</p>
</div><p><strong>About 1st Detect</strong></p>
<div class="lb-trans"><p><strong>关于 1st Detect</strong></p>
</div><p>Based in Austin, Texas, 1st Detect develops, manufactures, and sells trace detectors for security and detection markets. A subsidiary of Astrotech Corporation (Nasdaq: ASTC), the company's TRACER 1000 ETD® and TRACER 1000 NTD™ systems deliver laboratory-grade performance in portable designs built for real-world environments.</p>
<div class="lb-trans"><p>1st Detect 总部位于德克萨斯州奥斯丁，开发、制造和销售用于安全和检测市场的痕量探测器。作为 Astrotech Corporation（纳斯达克：ASTC）的子公司，该公司的 TRACER 1000 ETD®和 TRACER 1000 NTD™系统在为现实环境设计的便携式设备中提供实验室级别的性能。</p>
</div><p>For more information, visit https://1stdetect.com.</p>
<div class="lb-trans"><p>欲了解更多信息，请访问 https://1stdetect.com。</p>
</div><p><strong>About Astrotech Corporation</strong></p>
<div class="lb-trans"><p><strong>关于 Astrotech Corporation</strong></p>
</div><p>Astrotech Corporation (Nasdaq: ASTC) is a mass spectrometry company that creates, operates, and scales innovative businesses through its wholly owned subsidiaries. Each subsidiary leverages Astrotech’s core technology to serve specialized markets:</p>
<div class="lb-trans"><p>Astrotech Corporation（纳斯达克：ASTC）是一家质谱公司，通过其全资子公司创建、运营和扩展创新业务。每个子公司利用 Astrotech 的核心技术服务于专业市场：</p>
</div><ul>
<li>1st Detect develops, manufactures, and markets trace detection systems for security and narcotics screening applications.</li>
<li>AgLAB designs process analyzers tailored to the agriculture industry.</li>
<li>Pro-Control produces solutions for in-situ chemical process control in industrial manufacturing.</li>
<li>BreathTech is advancing a breath analysis platform to detect volatile organic compounds (VOCs) associated with infections and critical health conditions.</li>
<li>EN-SCAN, Inc. delivers portable, ruggedized environmental testing solutions that integrate gas chromatography and mass spectrometry for use in challenging field environments.</li>
</ul>
<div class="lb-trans"><ul>
<li>1st Detect 开发、制造和销售用于安全和毒品筛查应用的痕量检测系统。</li>
<li>AgLAB 设计针对农业行业的过程分析仪。</li>
<li>Pro-Control 生产用于工业制造中的原位化学过程控制的解决方案。</li>
<li>BreathTech 正在推进一种呼吸分析平台，以检测与感染和重大健康状况相关的挥发性有机化合物（VOCs）。</li>
<li>EN-SCAN, Inc.提供便携式、坚固的环境测试解决方案，集成气相色谱和质谱，适用于具有挑战性的现场环境。</li>
</ul>
</div><p>Astrotech is headquartered in Austin, Texas. For more information, visit https://www.astrotechcorp.com.</p>
<div class="lb-trans"><p>Astrotech 总部位于德克萨斯州奥斯丁。欲了解更多信息，请访问 https://www.astrotechcorp.com。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include the words “may,” “will,” “plans,” “believes,” “estimates,” “expects,” “intends,” and other similar expressions. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, the adverse impact of inflationary pressures, including significant increases in fuel costs, global economic conditions and events related to these conditions, including the ongoing wars in Ukraine and the middle east, the Company’s use of proceeds from the common stock offerings, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, whether the market will accept our products and services and whether we are successful in identifying, completing and integrating acquisitions, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements in this document should be evaluated in light of these important risk factors. While we do not intend to directly harvest, manufacture, distribute or sell cannabis or cannabis products, we may be detrimentally affected by a change in enforcement by federal or state governments and we may be subject to additional risks in connection with the evolving regulatory area and associated uncertainties. Any such effects may give rise to risks and uncertainties that are currently unknown or amplify others mentioned herein. Although the Company believes the expectations reflected in its forward-looking statements are reasonable and are based on reasonable assumptions, no assurance can be given that these assumptions are accurate or that any of these expectations will be achieved (in full or at all) or will prove to have been correct. Moreover, such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements. In addition, any forward-looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to correct or update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.</p>
<div class="lb-trans"><p>本新闻稿包含根据 1995 年《私人证券诉讼改革法案》的安全港条款所作的前瞻性声明。前瞻性声明可能包括 “可能”、“将”、“计划”、“相信”、“估计”、“期望”、“打算” 等类似表达。这些前瞻性声明受到风险、趋势和不确定性的影响，这些因素可能导致实际结果与前瞻性声明存在重大差异。这些因素包括但不限于通货膨胀压力的负面影响，包括燃料成本的显著增加、全球经济状况及与这些状况相关的事件，包括乌克兰和中东的持续战争、公司对普通股发行收益的使用、我们是否能够成功完成新产品和专有技术的开发、我们是否能够获得在美国或国外市场销售我们正在开发的产品所需的 FDA 及其他监管批准、市场是否会接受我们的产品和服务，以及我们在识别、完成和整合收购方面的成功与否，以及公司在证券交易委员会的备案文件中描述的其他风险因素和商业考虑，包括公司最近的 10-K 表格年度报告和 10-Q 表格季度报告。本文档中的任何前瞻性声明应根据这些重要风险因素进行评估。虽然我们不打算直接收获、制造、分销或销售大麻或大麻产品，但我们可能会受到联邦或州政府执法变化的负面影响，并且我们可能会面临与不断变化的监管领域及相关不确定性有关的额外风险。任何此类影响可能会导致当前未知的风险和不确定性，或加剧本文提到的其他风险。尽管公司相信其前瞻性声明中反映的预期是合理的，并基于合理的假设，但不能保证这些假设是准确的，或这些预期中的任何一个（全部或部分）将会实现，或将被证明是正确的。此外，这些声明受到许多假设、风险和不确定性的影响，其中许多超出了公司的控制范围，可能导致实际结果与前瞻性声明所暗示或表达的结果存在重大差异。此外，本新闻稿中包含的任何前瞻性声明仅代表公司在发布之日的观点，不应被视为公司在任何后续日期的观点。公司不承担因新信息、未来事件或其他原因而更正或更新这些前瞻性声明的义务，除非适用法律要求。</p>
</div><p><strong>Investor Contact: Matt Kreps, Managing Director, Darrow Associates, (214) 597-8200, mkreps@darrowir.com.</strong></p>
<div class="lb-trans"><p><strong>投资者联系：Matt Kreps，董事总经理，Darrow Associates，(214) 597-8200，mkreps@darrowir.com。</strong></p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZd01UWTFOU00zTXpJd016STRJelV3TURFd09EQTVPUT09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYwMTY1NSM3MzIwMzI4IzUwMDEwODA5OQ=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MjhhMWZlMjYtMDQwYi00MjQ4LTlkNzktMmJiOWFmZThmMTcxLTUwMDEwODA5OS0yMDI1LTEyLTEyLWVu/tiny/Astrotech-Corporation.png" alt="" original-src="https://ml.globenewswire.com/media/MjhhMWZlMjYtMDQwYi00MjQ4LTlkNzktMmJiOWFmZThmMTcxLTUwMDEwODA5OS0yMDI1LTEyLTEyLWVu/tiny/Astrotech-Corporation.png"/></p>

1st Detect 的航空安全技术已准备好支持美国航空安全现代化计划 | ASTC 股票新闻